ADIM
CTSH icon

Alpha DNA Investment Management’s Cognizant CTSH Stock Holding History

Alpha DNA Investment Management’s Portfolio CTSH Stock Details CTSH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-116
Closed -$9K – 217
2021
Q1 		$9K Buy
116
+77
+197% +$5.95K 0.01% 293
2020
Q4 		$3K Buy
+39
New +$2.97K ﹤0.01% 413

Other funds holding CTSH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Alpha DNA Investment Management's CTSH Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Cognizant (CTSH) in Q2 2021, closing a stake of 116 shares — an estimated $9K sold.

Alpha DNA Investment Management first reported a position in CTSH in Q4 2020 and held it in 2 quarters. The position peaked at $9K in Q1 2021. 882 funds tracked by Wall St. Rank hold CTSH as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Cognizant position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 116 Cognizant shares in Q2 2021, an estimated $9K.
  • Alpha DNA Investment Management first reported a position in Cognizant in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's Cognizant position peaked at $9K in Q1 2021.
  • 882 funds tracked by Wall St. Rank held Cognizant as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.